Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma.
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 18 Jun 2012 Actual end date (1 Jul 2007) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2006 Status change